Surprisingly, no correlation has yet been detected between IL-32 and age or sex, though only one limited study has so far been reported, with included patients of a maximum of 60 years old, with the number of HCC patients from the younger group being almost 4 times more than these from the older cohort (72 vs. 28) (28). Here, IL32 is linked to hepatocellular carcinoma.